(Q24187250)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Pharmacotherapy for cannabis dependence: how close are we?

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Marijuana dependence and its treatment

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Nicotine replacement therapy for smoking cessation

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Cannabis Use and Earlier Onset of Psychosis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Adverse health effects of marijuana use

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Adverse health effects of non-medical cannabis use

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Initiation of abstinence in adolescents treated for marijuana use disorders

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Bupropion reduces some of the symptoms of marihuana withdrawal in chronic marihuana users: a pilot study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substance use disorders

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Characterizing smoking topography of cannabis in heavy users

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

An overview of systematic reviews on cannabis and psychosis: discussing apparently conflicting results

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

A placebo-controlled trial of buspirone for the treatment of marijuana dependence

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

The chronic effects of cannabis on memory in humans: a review

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Cannabis withdrawal in the United States: results from NESARC.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Is there evidence for symptoms of cannabis withdrawal in the national epidemiologic survey of alcohol and related conditions?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Cannabis withdrawal predicts severity of cannabis involvement at 1-year follow-up among treated adolescents.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Use of dronabinol for cannabis dependence: two case reports and review

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Atomoxetine for treatment of marijuana dependence: a report on the efficacy and high incidence of gastrointestinal adverse events in a pilot study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Treatment of cannabis use disorders: a review of the literature

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

The cannabis withdrawal syndrome

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Cannabis withdrawal among non-treatment-seeking adult cannabis users

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Increasing treatment options for cannabis dependence: a review of potential pharmacotherapies

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Surveillance of drug use among American Indian adolescents: patterns over 25 years

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

The time course and significance of cannabis withdrawal

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Clinical profile of participants in a brief intervention program for cannabis use disorder

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Psychotropic analgesic nitrous oxide prevents craving after withdrawal for alcohol, cannabis and tobacco

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Baclofen in the management of cannabis dependence syndrome

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Interaction between naltrexone and oral THC in heavy marijuana smokers.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Early findings from a pharmacokinetically designed double-blind and placebo-controlled study of lithium for adolescents comorbid with bipolar and substance dependency disorders

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4297244

Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium

30 May 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

Treatment of cannabis dependence using escitalopram in combination with cognitive-behavior therapy: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

Combined cannabis/methaqualone withdrawal treated with psychotropic analgesic nitrous oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

Bupropion SR worsens mood during marijuana withdrawal in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

Nefazodone decreases anxiety during marijuana withdrawal in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

Effects of oral THC maintenance on smoked marijuana self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

Buspirone for treatment of marijuana dependence: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

Baclofen in cannabis dependence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

Emerging patterns of cannabis and other substance use in Aboriginal communities in Arnhem Land, Northern Territory: a study of two communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

Attributes of long-term heavy cannabis users: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

Cannabis use and cannabis use disorders among individuals with mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: results from a large representative sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

Prospective assessment of cannabis withdrawal in adolescents with cannabis dependence: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

Fluoxetine versus placebo for the marijuana use of depressed alcoholics

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25515775

12 December 2020

inferred from PubMed ID database lookup

Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25515775

12 December 2020

inferred from PubMed ID database lookup

Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25515775

12 December 2020

inferred from PubMed ID database lookup

Poster Session III-Wednesday: Wednesday, December 11, 2013

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

7 January 2021

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008940.PUB2

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD008940.PUB2

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4425594

OpenCitations bibliographic resource ID

4425594

1 reference